Biotechnology company developing precision-engineered siRNA therapeutics that silence disease-associated genes without permanently altering DNA
Biotechnology company developing precision-engineered siRNA therapeutics that silence disease-associated genes without permanently altering DNA. Its clinical programs focus on hematology, cardiovascular and rare diseases.